Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Animal Health Companies

Animal health companies are organizations dedicated to the research, development, production, and distribution of a wide range of pharmaceuticals, vaccines, medical devices, and other healthcare products for animals. These companies play a crucial role in ensuring the health, welfare, and well-being of domestic pets, livestock, poultry, aquatic animals, and wildlife.

Animal Health Market*Disclaimer: List of key companies in no particular orderLatest Animal health Companies Update



  • August 2023: Boehringer Ingelheim expanded its portfolio of animal health products with the introduction of NexGard in India in August 2023. The expansion of the NexGard product line for tiny (weighing two to four kilograms) and medium (weighing four to ten kilograms) canines follows the successful launch of NexGard X and L earlier in 2020. NexGard is indicated for use in dogs and puppies as young as eight weeks and is administered monthly in highly palatable chewables that eliminate fleas, ticks, and mites before they can deposit eggs. The product is the only product approved by the FDA to prevent Lyme disease in canines by eliminating black-legged ticks. With the introduction of NexGard S and M, Boehringer Ingelheim intends to provide the same level of protection to small and medium-sized canines as to larger dogs.




  • October 2023: Athersys, Inc., a cell therapy and regenerative medicine company developed MultiStem for critical care indications and Multipotent Adult Progenitor Cell (MAPC) technology for equine, canine, and feline health applications, has signed a licensing agreement with Ardent Animal Health. Ardent is a privately held veterinary biotechnology company developing cancer treatments and regenerative medicine for animals. Ardent will pay an upfront fee to Athersys in exchange for an exclusive license to Athersys' Multipotent Adult Progenitor Cell (MAPC) technology for non-human mammal applications in the United States. The agreement comprises pre- and post-regulatory approval milestone payments for Athersys, including conditional and complete product approval payments for each species/indication combination. Athersys will also receive tiered royalties in the double-digit percentage range on commercial sales.


List of Animal health Key companies in the market

  • Bayer AG

  • Boehringer Ingelheim GmbH

  • Virbac SA

  • Zoetis, Inc.

  • Hester Biosciences Ltd.

  • Intas Pharmaceuticals Ltd.

  • Merck Animal Health

  • Elanco (Eli Lilly and Company)

  • Ceva Santé Animale

  • Alvira Animal Health Limited

  • Vetoquinol S.A.

  • Zydus Animal Health

  • Norbrook Laboratories Limited

  • Phibro Animal Health Corporation

  • Dechra Pharmaceuticals PLC Norbrook Laboratories

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.